Outlook Therapeutics OTLK reported its Q4 earnings results on Wednesday, December 22, 2021 at 08:00 AM.
Here's what investors need to know about the announcement.
Outlook Therapeutics missed estimated earnings by 33.33%, reporting an EPS of $-0.08 versus an estimate of $-0.06, which surprised analysts.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0, which was followed by a 5.14% drop in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.